The nation's blood supply is facing a critical shortage due to a combination of factors, including a drop in donors during the holiday season.

When someone inherits two mutant copies of the hemoglobin gene, the abnormal form of the hemoglobin protein causes the red blood cells to lose oxygen and warp into a sickle shape during periods of ...

A once-groundbreaking sickle cell disease drug — at the center of a $5.4 billion acquisition two years ago — is the subject ...

More than 500,000 babies were tested for sickle cell disease in Catalonia’s newborn screening program, with 160 cases ...

The following is a summary of “Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 ...

warping the red blood cells they rode in, blocking her circulation. Now, throughout the U.S., hospitals take a prick of blood from every newborn’s heel and test it for sickle cell disease.

"This world-leading research lays the groundwork for the manufacture of red blood cells that can safely be used to transfuse people with disorders like sickle cell. "The potential for this work to ...

Sickle cell disease affects around 8 million people worldwide. It is caused by mutations in the β-globin protein that warp red blood cells and cause periodic pain crises and serious health ...

But in people with weakened immune systems or sickle cell disease, the virus can lead to more severe symptoms, such as a significant drop in red blood cell production (anemia). If a pregnant woman ...